To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CREB3L4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
239 supporting clones for gene CREB3L4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA604408   .a 1 to 508 2 to 509   tiling clone, capped   508/508
(100 %)
1 diff
(99.9 %id)
DB320029   .a 1247 to 1749 504 to 1   tiling clone,   504/509
(99 %)
2 diff
(99.7 %id)
BM556950 melanotic melanoma, skin .b 1 to 830 13 to 853   tiling clone,   841/1072
(78 %)
25 diff
(97.7 %id)
BM829447 Ascites, stomach .b 282 to 934 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
DB003504 breast, tumor tissue .b 302 to 837 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DA745537   .b 303 to 867 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA612556   .b 315 to 884 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DA612568   .b 315 to 882 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
BM847125 myeloma .b 316 to 880 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BM846663 myeloma .b 316 to 824 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BM846254 myeloma .b 316 to 824 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BM848357 myeloma .b 316 to 935 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
DA616466   .b 317 to 911 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
BM848656 myeloma .b 317 to 845 1 to 530       530/530
(100 %)
5 diff
(99.1 %id)
BU844957 ovary, teratocarcinoma, cell line .b 321 to 1146 1 to 830       830/930
(89 %)
10 diff
(99.0 %id)
BM743681 Ascites, stomach .b 329 to 933 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
AY049977   .b 330 to 2074 1 to 1745 exact tiling clone, AAA   1745/1745
(100 %)
0 diff
(100 %id)
AV760771 bone marrow .b 330 to 978 1 to 645       645/674
(95 %)
4 diff
(99.5 %id)
AL528908 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 332 to 1111 1 to 780       780/780
(100 %)
0 diff
(100 %id)
CD683880 normal nasopharynx .b 335 to 987 24 to 677       654/677
(96 %)
7 diff
(99.0 %id)
CD692634 normal nasopharynx .b 335 to 850 23 to 540       518/540
(95 %)
7 diff
(98.8 %id)
BE251158 eye, retinoblastoma .b 337 to 992 1 to 650       650/699
(92 %)
15 diff
(97.9 %id)
DA909633   .b 340 to 913 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BI087317 cervix .b 342 to 1087 1 to 747       747/748
(99 %)
5 diff
(99.4 %id)
CX761747 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 344 to 1027 1 to 683     Submitted on the opposite strand 683/683
(100 %)
3 diff
(99.6 %id)
BE782484 eye, retinoblastoma .b 347 to 1101 1 to 743       744/923
(80 %)
27 diff
(97.1 %id)
CR592077 Neuroblastoma Cot 25-normalized .b 348 to 2027 1 to 1680 exact     1680/1680
(100 %)
0 diff
(100 %id)
AL527998 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 348 to 1232 1 to 883   fully sequenced,   883/883
(100 %)
4 diff
(99.6 %id)
BM546322 ovary (pool of 3) .b 350 to 1331 18 to 1000       983/1078
(91 %)
27 diff
(97.5 %id)
BG763732 melanotic melanoma, high MDR (cell line), skin .b 351 to 1053 1 to 704       704/705
(99 %)
3 diff
(99.6 %id)
BX337040 Placenta Cot 25-normalized .b 354 to 1301 1 to 949   fully sequenced,   949/949
(100 %)
2 diff
(99.8 %id)
BC038962 Skin, melanotic melanoma. .b 355 to 2074 12 to 1731 exact available from MGC, AAA   1720/1720
(100 %)
0 diff
(100 %id)
BQ224313 melanotic melanoma, skin .b 356 to 1136 1 to 788       788/914
(86 %)
11 diff
(98.8 %id)
BG257502 embryonal carcinoma, cell line, testis .b 357 to 971 1 to 616       616/616
(100 %)
3 diff
(99.6 %id)
DB251514 uterus .b 365 to 886 2 to 524   capped   523/523
(100 %)
2 diff
(99.7 %id)
BX328304   .b 504 to 1413 1 to 903       903/961
(93 %)
67 diff
(93.1 %id)
BX390974   .b 505 to 1006 1 to 507       507/767
(66 %)
29 diff
(96.3 %id)
EL733750 mixed .b 596 to 1267 1 to 668       670/673
(99 %)
10 diff
(98.6 %id)
CD722502 eye, lacrimal gland .b 770 to 1384 7 to 621       615/622
(98 %)
1 diff
(99.9 %id)
BF037247 adenocarcinoma, ovary .b 911 to 1590 1 to 675       677/933
(72 %)
15 diff
(98.4 %id)
BM987499 mixed .b 925 to 1381 457 to 1       457/457
(100 %)
8 diff
(98.3 %id)
AL563026 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1201 to 2027 834 to 1   fully sequenced,   834/834
(100 %)
13 diff
(98.5 %id)
AL563283 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 1225 to 2068 843 to 1       843/847
(99 %)
5 diff
(99.5 %id)
BX373385 Placenta Cot 25-normalized .b 1271 to 2073 811 to 1   fully sequenced,   811/811
(100 %)
25 diff
(97.0 %id)
AF468007   .c 1 to 1592 1 to 1592 P35L tiling clone,   1592/1592
(100 %)
3 diff
(99.9 %id)
BP331240 rectum .c 23 to 606 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BG699998 brain, hippocampus .c 33 to 721 1 to 691       691/691
(100 %)
13 diff
(98.2 %id)
AF394167   .c 40 to 1603 1 to 1564 exact tiling clone,   1564/1564
(100 %)
0 diff
(100 %id)
CF141191 CNCAP(3)T-225 cell line, Prostate .c 48 to 527 1 to 480       480/480
(100 %)
6 diff
(98.8 %id)
CD697576 normal nasopharynx .c 50 to 536 35 to 522       488/522
(93 %)
7 diff
(98.7 %id)
BU599097 mixed (pool of 40 RNAs) .c 52 to 754 1 to 706       706/782
(90 %)
12 diff
(98.5 %id)
DC365392 ovary .c 53 to 618 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC393387 cervix, tumor tissue .c 53 to 620 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC392543 stomach .c 55 to 596 1 to 542       542/542
(100 %)
2 diff
(99.7 %id)
TI_154171837   .c 55 to 611 79 to 635       557/560
(99 %)
10 diff
(98.3 %id)
AI682937 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 63 to 474 26 to 437     Submitted on the opposite strand 412/437
(94 %)
6 diff
(98.7 %id)
CB069806 Pancreas, Purified pancreatic islet .c 65 to 485 1 to 421       421/421
(100 %)
2 diff
(99.6 %id)
CB069862 Pancreas, Purified pancreatic islet .c 67 to 514 9 to 456       448/456
(98 %)
6 diff
(98.7 %id)
DN995897 breast cancer, Mammary gland (cancer tissue) .c 67 to 690 9 to 632       624/632
(98 %)
6 diff
(99.1 %id)
BQ950696 sciatic nerve .c 69 to 861 1 to 794       794/926
(85 %)
15 diff
(98.4 %id)
CA454251   .c 71 to 958 1 to 901       899/908
(99 %)
16 diff
(98.3 %id)
CA454066   .c 75 to 543 1 to 469   AAA   469/910
(51 %)
8 diff
(99.2 %id)
BE791917 lung, small cell carcinoma .c 83 to 869 1 to 781       783/848
(92 %)
26 diff
(97.0 %id)
TI_1948156357   .c 116 to 906 127 to 915   fully sequenced,   789/915
(86 %)
7 diff
(99.3 %id)
TI_1948156526   .c 116 to 908 120 to 912   fully sequenced,   793/912
(86 %)
6 diff
(99.4 %id)
TI_1948156704   .c 116 to 910 126 to 920   fully sequenced,   795/920
(86 %)
8 diff
(99.2 %id)
TI_1948156880   .c 116 to 960 123 to 967   fully sequenced,   845/967
(87 %)
6 diff
(99.4 %id)
TI_1948156358   .c 876 to 1599 909 to 186   fully sequenced, AAA   724/909
(79 %)
1 diff
(99.9 %id)
TI_1948156527   .c 878 to 1599 908 to 187   fully sequenced, AAA   722/908
(79 %)
3 diff
(99.7 %id)
TI_1948156705   .c 880 to 1599 906 to 187   fully sequenced, AAA   720/906
(79 %)
0 diff
(100 %id)
TI_1948156881   .c 899 to 1599 885 to 185   fully sequenced, AAA   701/885
(79 %)
0 diff
(100 %id)
N23545 melanocyte .c 910 to 1227 1 to 322   fully sequenced,   322/322
(100 %)
3 diff
(99.1 %id)
BM977529 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 910 to 1596 705 to 19   AAA   687/687
(100 %)
0 diff
(100 %id)
BI857189 breast, mammary adenocarcinoma, cell line .c 927 to 1607 5 to 682       678/695
(97 %)
17 diff
(97.6 %id)
TI_57186852   .c 927 to 1607 60 to 737       678/926
(73 %)
15 diff
(98.4 %id)
N41881 placenta .c 943 to 1300 1 to 372       372/372
(100 %)
20 diff
(94.7 %id)
BI907666 leukocyte .c 962 to 1582 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
TI_57234035   .c 962 to 1582 30 to 650       621/650
(95 %)
6 diff
(99.1 %id)
AA229977   .c 981 to 1305 1 to 325       325/325
(100 %)
3 diff
(99.1 %id)
CA748975 cell lines, Chondrosarcoma .c 984 to 1596 631 to 19   AAA   613/613
(100 %)
2 diff
(99.7 %id)
BU632663 cell lines, Chondrosarcoma .c 991 to 1603 631 to 19   AAA   613/613
(100 %)
1 diff
(99.9 %id)
BM990629 lung, Lung Focal Fibrosis .c 1016 to 1564 565 to 16   AAA   550/583
(94 %)
3 diff
(99.5 %id)
EC448149 Prostate .c 1024 to 1121 1 to 93       93/93
(100 %)
7 diff
(92.5 %id)
EC544527 Prostate .c 1029 to 1118 1 to 90       90/90
(100 %)
0 diff
(100 %id)
AW270016 lung, two pooled squamous cell carcinomas .c 1030 to 1604 575 to 1       575/575
(100 %)
3 diff
(99.5 %id)
FN069372 breast carcinoma .c 1061 to 1123 1 to 63       63/64
(98 %)
1 diff
(98.5 %id)
AI188850 placenta .c 1082 to 1502 433 to 13   AAA   421/421
(100 %)
2 diff
(99.6 %id)
BP390944 pancreatic islet .c 1095 to 1596 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
AW748203 breast .c 1101 to 1300 1 to 200       200/200
(100 %)
11 diff
(94.5 %id)
TI_149301889   .c 1107 to 1596 572 to 84   AAA   489/556
(87 %)
5 diff
(99.2 %id)
BM980172 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1107 to 1596 507 to 19   AAA   489/520
(94 %)
5 diff
(99.1 %id)
AW369862 breast .c 1110 to 1300 1 to 191       191/191
(100 %)
8 diff
(95.9 %id)
FN145488 breast carcinoma .c 1111 to 1217 1 to 106       106/106
(100 %)
1 diff
(99.1 %id)
BM850446 stomach .c 1111 to 1602 1 to 491       491/491
(100 %)
4 diff
(99.2 %id)
AI872842 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1124 to 1598 493 to 1       493/552
(89 %)
6 diff
(99.0 %id)
BF592041 Kidney .c 1126 to 1599 479 to 6       474/479
(98 %)
0 diff
(100 %id)
EC451683 Prostate .c 1137 to 1231 1 to 96       96/102
(94 %)
6 diff
(94.2 %id)
EC495579 Prostate .c 1137 to 1231 1 to 96       96/101
(95 %)
6 diff
(94.1 %id)
EC488944 Prostate .c 1138 to 1231 11 to 105       95/105
(90 %)
6 diff
(94.3 %id)
CB048012 Prostate .c 1148 to 1596 3 to 451   AAA   449/451
(99 %)
6 diff
(98.7 %id)
AW151216 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1154 to 1599 450 to 5       446/450
(99 %)
0 diff
(100 %id)
AI927130 normal prostate, Prostate .c 1157 to 1597 441 to 1       441/443
(99 %)
0 diff
(100 %id)
AW027702 thymus, pooled .c 1160 to 1603 445 to 1       445/445
(100 %)
5 diff
(98.9 %id)
AI658538 Prostate .c 1163 to 1603 467 to 26   AAA   442/442
(100 %)
12 diff
(97.3 %id)
AI961528 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1167 to 1596 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
W92231 heart .c 1178 to 1603 1 to 426   fully sequenced,   426/426
(100 %)
3 diff
(99.3 %id)
AA011250 heart .c 1178 to 1604 1 to 436   fully sequenced,   436/436
(100 %)
11 diff
(97.5 %id)
AI263970 adenocarcinoma, colon .c 1188 to 1599 415 to 4       412/415
(99 %)
0 diff
(100 %id)
BF589634 Prostate .c 1188 to 1596 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AA972598 pooled .c 1193 to 1599 412 to 6       407/412
(98 %)
0 diff
(100 %id)
AI028440 parathyroid gland, parathyroid tumor .c 1194 to 1596 413 to 11   AAA   403/403
(100 %)
0 diff
(100 %id)
AI872174 ovary, tumor, 5 pooled (see description) .c 1195 to 1596 402 to 1       402/403
(99 %)
0 diff
(100 %id)
CB068592 Pancreas, Purified pancreatic islet .c 1195 to 1595 401 to 1       401/401
(100 %)
0 diff
(100 %id)
H98820 melanocyte .c 1197 to 1603 407 to 1   fully sequenced,   407/407
(100 %)
2 diff
(99.6 %id)
AI369603 anaplastic oligodendroglioma, brain .c 1202 to 1599 404 to 7       398/404
(98 %)
0 diff
(100 %id)
AI807881 pooled .c 1202 to 1596 409 to 15   AAA   395/395
(100 %)
2 diff
(99.5 %id)
AI151181 placenta .c 1204 to 1595 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AI469514 colon, moderately-differentiated adenocarcinoma .c 1205 to 1596 402 to 12   AAA   391/391
(100 %)
1 diff
(99.8 %id)
AI130985 heart .c 1211 to 1603 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AI928081 normal prostate, Prostate .c 1211 to 1599 394 to 6       389/394
(98 %)
0 diff
(100 %id)
AA503719 colon .c 1215 to 1599 390 to 6       385/390
(98 %)
0 diff
(100 %id)
AA034239 heart .c 1217 to 1597 1 to 382       382/382
(100 %)
3 diff
(99.3 %id)
FN048631 breast carcinoma .c 1221 to 1310 1 to 90       90/90
(100 %)
0 diff
(100 %id)
AI052150 liver and spleen .c 1224 to 1597 374 to 1       374/374
(100 %)
4 diff
(99.0 %id)
CB068529 Pancreas, Purified pancreatic islet .c 1230 to 1595 366 to 1       366/366
(100 %)
0 diff
(100 %id)
FN108666 breast carcinoma .c 1235 to 1313 1 to 77       77/88
(87 %)
3 diff
(96.6 %id)
AI493479 anaplastic oligodendroglioma, brain .c 1240 to 1599 366 to 7       360/366
(98 %)
0 diff
(100 %id)
FN132885 breast carcinoma .c 1241 to 1311 1 to 69       69/70
(98 %)
3 diff
(95.8 %id)
AI287333 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1253 to 1604 352 to 1   tiling clone,   352/352
(100 %)
1 diff
(99.8 %id)
AA724525 pooled .c 1255 to 1599 347 to 3       345/347
(99 %)
0 diff
(100 %id)
AA587806 normal prostate, Prostate .c 1268 to 1597 330 to 1       330/330
(100 %)
0 diff
(100 %id)
BM830446 stomach .c 1269 to 1595 1 to 328       328/328
(100 %)
4 diff
(98.8 %id)
AA677752 liver and spleen .c 1278 to 1596 318 to 1       318/318
(100 %)
1 diff
(99.7 %id)
AI919049 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1281 to 1597 319 to 1       319/319
(100 %)
5 diff
(98.5 %id)
AA468167   .c 1299 to 1597 45 to 343       299/343
(87 %)
6 diff
(98.3 %id)
EC487913 Prostate .c 1304 to 1399 15 to 110       96/110
(87 %)
6 diff
(94.6 %id)
EC443663 Prostate .c 1305 to 1406 1 to 101       101/111
(90 %)
2 diff
(98.2 %id)
BU742223 eye, fetal eye .c 1314 to 1596 305 to 19   AAA   287/287
(100 %)
3 diff
(99.0 %id)
EC504060 Prostate .c 1319 to 1429 1 to 111       111/111
(100 %)
0 diff
(100 %id)
EC538340 Prostate .c 1319 to 1429 1 to 111       111/111
(100 %)
0 diff
(100 %id)
AI200779   .c 1332 to 1599 273 to 6       268/273
(98 %)
0 diff
(100 %id)
AA010641 heart .c 1334 to 1511 178 to 1   fully sequenced,   178/178
(100 %)
2 diff
(98.9 %id)
FN173023 breast carcinoma .c 1340 to 1452 1 to 114       114/114
(100 %)
1 diff
(99.2 %id)
AW769704 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 1344 to 1603 261 to 1       261/261
(100 %)
3 diff
(98.9 %id)
AI185369 lung .c 1345 to 1604 262 to 3       260/263
(98 %)
0 diff
(100 %id)
FN167408 breast carcinoma .c 1349 to 1458 1 to 110       110/110
(100 %)
0 diff
(100 %id)
EC573577 Prostate .c 1364 to 1457 1 to 94       94/94
(100 %)
0 diff
(100 %id)
AA937323 Kidney, kidney tumor .c 1405 to 1596 205 to 15   AAA   191/191
(100 %)
1 diff
(99.5 %id)
AI001818   .c 1408 to 1599 194 to 3       192/194
(98 %)
0 diff
(100 %id)
W94941 heart .c 1410 to 1604 198 to 1   fully sequenced,   198/198
(100 %)
1 diff
(99.5 %id)
AI864696 lymph node, lymphoma, follicular mixed small and largecell .c 1429 to 1599 172 to 2       171/183
(93 %)
0 diff
(100 %id)
DB012316 esophageal, tumor tissue .d 1 to 534 2 to 536   tiling clone, capped   535/535
(100 %)
1 diff
(99.9 %id)
DA050384   .d 56 to 635 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
CR610829 Neuroblastoma Cot 25-normalized .d 60 to 1800 1 to 1741 exact     1741/1741
(100 %)
0 diff
(100 %id)
AL528505 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 60 to 923 1 to 864   fully sequenced,   864/864
(100 %)
0 diff
(100 %id)
BP227763   .d 64 to 613 1 to 550       550/550
(100 %)
8 diff
(98.6 %id)
BP269628 thyroid .d 66 to 644 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DB043260 testis .d 70 to 645 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BX332272 Neuroblastoma Cot 25-normalized .d 79 to 985 1 to 899       899/962
(93 %)
10 diff
(99.0 %id)
BF347981 anaplastic oligodendroglioma with 1p/19qloss, brain .d 79 to 825 1 to 746       746/746
(100 %)
10 diff
(98.7 %id)
AB052778   .d 82 to 1828 1 to 1747 exact tiling clone,   1747/1747
(100 %)
0 diff
(100 %id)
NM_130898.2   .d 82 to 1828 1 to 1747 exact RefSeq,   1747/1747
(100 %)
0 diff
(100 %id)
AA203110 liver and spleen .d 83 to 756 1 to 667       667/906
(73 %)
19 diff
(98.0 %id)
BE784249 eye, retinoblastoma .d 94 to 777 1 to 687       687/1068
(64 %)
12 diff
(98.9 %id)
AA465513 germinal center B cell .d 100 to 591 1 to 491       491/491
(100 %)
5 diff
(99.0 %id)
BI916930 brain .d 115 to 833 1 to 719       719/719
(100 %)
7 diff
(99.1 %id)
TI_57239450   .d 115 to 833 28 to 746       719/746
(96 %)
11 diff
(98.6 %id)
AL528465 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 873 to 1800 928 to 1   fully sequenced,   928/928
(100 %)
12 diff
(98.8 %id)
AA465402 germinal center B cell .d 1690 to 1828 158 to 20   AAA   139/139
(100 %)
1 diff
(99.3 %id)
BX647716 human prostate .e 1 to 1494 1 to 1494 L167P tiling clone, available from DKFZ, AAA   1494/1494
(100 %)
3 diff
(99.8 %id)
DN912170   .e 12 to 334 1 to 323       323/323
(100 %)
11 diff
(96.6 %id)
CA489762   .e 25 to 913 24 to 913   tiling clone,   890/931
(95 %)
15 diff
(98.4 %id)
BX332121 Neuroblastoma Cot 25-normalized .f 2 to 754 1 to 752       752/752
(100 %)
5 diff
(99.4 %id)
BM903818 eye, retinoblastoma .f 13 to 971 1 to 963   tiling clone,   965/975
(98 %)
24 diff
(97.6 %id)
AK304665 uterus .f 40 to 1666 1 to 1627 exact     1627/1627
(100 %)
0 diff
(100 %id)
DC421902 uterus .f 40 to 604 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DC336435 substantia nigra .f 49 to 614 1 to 568       568/568
(100 %)
3 diff
(99.5 %id)
CR624438 Neuroblastoma Cot 10-normalized .f 50 to 1700 1 to 1651 exact tiling clone,   1651/1651
(100 %)
0 diff
(100 %id)
AL519764 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 50 to 808 1 to 760   fully sequenced,   760/760
(100 %)
1 diff
(99.9 %id)
BG911781 anaplastic oligodendroglioma with 1p/19qloss, brain .f 51 to 607 1 to 567       567/1025
(55 %)
22 diff
(97.9 %id)
CF139506 CNCAP(3)T-225 cell line, Prostate .f 62 to 576 8 to 522       515/522
(98 %)
7 diff
(98.7 %id)
TI_154169773   .f 62 to 662 80 to 681       602/886
(67 %)
7 diff
(99.3 %id)
BE250017 adenocarcinoma cell line, colon .f 66 to 875 1 to 807       807/929
(86 %)
23 diff
(97.6 %id)
BE305074 adenocarcinoma cell line, colon .f 66 to 659 1 to 587       587/599
(97 %)
14 diff
(97.7 %id)
CN335712 embryonic stem cells, DMSO-treated H9 cellline .f 67 to 806 9 to 748       740/748
(98 %)
6 diff
(99.2 %id)
BI765834 pooled colon, kidney, stomach .f 72 to 879 1 to 802       802/943
(85 %)
18 diff
(98.1 %id)
TI_57151646   .f 72 to 879 1 to 802       802/943
(85 %)
18 diff
(98.1 %id)
CD702480 normal nasopharynx .f 291 to 515 318 to 542       528/542
(97 %)
5 diff
(99.1 %id)
CA488878   .f 381 to 1139 1 to 761       761/884
(86 %)
9 diff
(99.0 %id)
AL519763 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 757 to 1700 943 to 1   fully sequenced,   943/943
(100 %)
4 diff
(99.6 %id)
BU597745 mixed (pool of 40 RNAs) .g 1 to 649 1 to 657   tiling clone,   657/921
(71 %)
11 diff
(98.9 %id)
CR621422 HeLa cells Cot 25-normalized .g 19 to 1679 1 to 1661 exact tiling clone,   1661/1661
(100 %)
0 diff
(100 %id)
AL556293 placenta .g 19 to 841 1 to 823   fully sequenced,   823/823
(100 %)
1 diff
(99.9 %id)
CB112699 Liver .g 22 to 577 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
CR624400 Neuroblastoma Cot 25-normalized .g 29 to 1595 1 to 1567 exact     1567/1567
(100 %)
0 diff
(100 %id)
AL526872 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 29 to 812 1 to 783   fully sequenced,   783/783
(100 %)
2 diff
(99.8 %id)
DC297638   .g 48 to 608 1 to 563       563/563
(100 %)
5 diff
(99.2 %id)
AL562761 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 751 to 1576 839 to 16   fully sequenced,   824/839
(98 %)
3 diff
(99.7 %id)
AL578588 placenta .g 811 to 1679 868 to 1   fully sequenced,   868/868
(100 %)
19 diff
(97.9 %id)
DA031208   .h 1 to 566 2 to 568   tiling clone, to resequence, capped   567/567
(100 %)
5 diff
(99.2 %id)
BF915467 uterus_tumor .h 440 to 956 526 to 9   tiling clone, Submitted on the opposite strand 518/533
(97 %)
0 diff
(100 %id)
CA389335 eye, RPE/choroid .h 498 to 1181 1 to 684   tiling clone,   684/684
(100 %)
3 diff
(99.6 %id)
BF915512 uterus_tumor .h 707 to 967 1 to 262       262/262
(100 %)
6 diff
(97.8 %id)
BM728444 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 780 to 1387 1 to 608   tiling clone,   608/608
(100 %)
1 diff
(99.9 %id)
BQ925615 sciatic nerve .h 1276 to 1823 1 to 552   tiling clone,   552/1068
(51 %)
13 diff
(98.8 %id)
DB295798   .h 2244 to 2783 540 to 1   tiling clone, to resequence,   540/540
(100 %)
0 diff
(100 %id)
AK297703 lung .i 1 to 1526 6 to 1531 exact tiling clone,   1531/1531
(100 %)
2 diff
(99.9 %id)
DC354721 lung .i 1 to 579 6 to 584       584/587
(99 %)
3 diff
(99.5 %id)
BM847044 myeloma .i 15 to 702 1 to 458   tiling clone,   458/458
(100 %)
0 diff
(100 %id)
BM846949 myeloma .i 15 to 367 1 to 353       353/353
(100 %)
5 diff
(98.6 %id)
CN281567 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 42 to 343 1 to 302       302/302
(100 %)
3 diff
(99.1 %id)
AL526785 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .i 470 to 1499 1027 to 1 V2C P3L D4I S5L C6H ...     1027/1027
(100 %)
24 diff
(97.7 %id)
EC447763 Prostate .i 499 to 587 89 to 1       89/91
(97 %)
0 diff
(100 %id)
BF681098 Prostate .i 509 to 1210 1 to 698       698/761
(91 %)
19 diff
(97.6 %id)
CD674840 eye, lens .i 511 to 1134 1 to 624   tiling clone,   624/624
(100 %)
0 diff
(100 %id)
AA336412 endometrium .i 542 to 789 1 to 250       250/270
(92 %)
6 diff
(97.8 %id)
CR746992 pooled colon, kidney, stomach .i 548 to 1055 1 to 508       508/508
(100 %)
0 diff
(100 %id)
TI_57150053   .i 550 to 1365 65 to 877       813/877
(92 %)
11 diff
(98.8 %id)
BI763386 pooled colon, kidney, stomach .i 551 to 1365 1 to 814       814/814
(100 %)
9 diff
(98.9 %id)
AW956672   .i 589 to 1084 20 to 517       497/526
(94 %)
17 diff
(96.8 %id)
EC496501 Prostate .i 592 to 684 1 to 94       94/109
(86 %)
2 diff
(98.2 %id)
AA345027 gall bladder .i 593 to 806 10 to 223       214/223
(95 %)
7 diff
(96.9 %id)
EC480544 Prostate .i 603 to 684 1 to 82       82/97
(84 %)
1 diff
(99.0 %id)
EC582681 Prostate .i 604 to 684 1 to 81       81/96
(84 %)
1 diff
(99.0 %id)
AA533650 invasive prostate tumor, Prostate .i 608 to 859 1 to 250       250/250
(100 %)
9 diff
(96.4 %id)
AA570171   .i 612 to 945 1 to 334       334/366
(91 %)
5 diff
(98.7 %id)
EC501106 Prostate .i 684 to 778 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
TI_149311758   .i 686 to 1526 915 to 86   AAA   830/984
(84 %)
20 diff
(98.0 %id)
H54240 liver and spleen .i 751 to 1176 1 to 431       431/431
(100 %)
9 diff
(98.0 %id)
H78888 liver and spleen .i 751 to 1125 1 to 383       383/386
(99 %)
11 diff
(97.2 %id)
FN047445 breast carcinoma .i 866 to 955 90 to 1     Submitted on the opposite strand 90/90
(100 %)
0 diff
(100 %id)
FN059599 breast carcinoma .i 875 to 968 95 to 1     Submitted on the opposite strand 95/95
(100 %)
1 diff
(99.0 %id)
CA394570 eye, RPE/choroid .j 1 to 568 1 to 567   tiling clone,   567/567
(100 %)
1 diff
(99.9 %id)
CB107441 Liver .j 306 to 630 1 to 324   tiling clone,   324/324
(100 %)
3 diff
(99.1 %id)
AA337698 endometrium .j 431 to 616 1 to 186       186/186
(100 %)
0 diff
(100 %id)
EC477136 Prostate .j 579 to 667 93 to 6   tiling clone,   88/93
(94 %)
0 diff
(100 %id)
FN135872 breast carcinoma .j 647 to 750 1 to 106   tiling clone,   106/106
(100 %)
3 diff
(97.2 %id)
BP375945 uterus .j 680 to 1258 1 to 581   tiling clone,   581/581
(100 %)
3 diff
(99.5 %id)
BF677734 Prostate .k 1 to 692 2 to 688 L13W E14S P16Q E17R D18I ... tiling clone,   688/858
(80 %)
39 diff
(95.5 %id)
DC404967 thymus .l 1 to 554 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
AK304259 trachea .l 2 to 1051 1 to 1050 exact tiling clone,   1050/1050
(100 %)
3 diff
(99.8 %id)
DC417438 trachea .l 2 to 604 1 to 603       603/603
(100 %)
0 diff
(100 %id)
CK429797 eye, lacrimal gland .l 8 to 619 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BM805043 ovary (pool of 3) .m -8 to 923 25 to 968 P95S tiling clone,   944/1074
(87 %)
28 diff
(97.4 %id)
CA489021   .m 548 to 1374 1 to 831   tiling clone,   831/920
(90 %)
6 diff
(99.4 %id)
TI_57180646   .n 1 to 879 60 to 939 S172Q G173W A174C I175N T176H ... tiling clone,   880/941
(93 %)
11 diff
(98.9 %id)
BI768195 pooled lung and spleen .n 9 to 879 1 to 872 S172Q G173W A174C I175N T176H ... tiling clone,   872/874
(99 %)
5 diff
(99.5 %id)
AK309767 brain .o 1 to 900 2 to 901 exact tiling clone,   901/901
(100 %)
1 diff
(99.9 %id)
DA772113 brain .o 1 to 548 2 to 550 exact capped   549/549
(100 %)
1 diff
(99.9 %id)
DA085941 cerebellum .p 1 to 458 2 to 459 exact tiling clone, capped   458/458
(100 %)
0 diff
(100 %id)
CA487547   .p 14 to 873 1 to 870 exact tiling clone,   870/896
(97 %)
11 diff
(98.8 %id)
BI833094 pooled pancreas and spleen .q 1 to 835 1 to 831 V29S P30A C31L T32Y T33N ... tiling clone,   833/832
(100 %)
22 diff
(97.4 %id)
TI_57168508   .q 1 to 835 101 to 931 V29S P30A C31L T32Y T33N ...     833/932
(89 %)
25 diff
(97.4 %id)
DA750444   .r 1 to 580 2 to 581 exact tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
CN335713 embryonic stem cells, DMSO-treated H9 cellline .s 1 to 443 8 to 451 exact tiling clone,   451/451
(100 %)
2 diff
(99.6 %id)
EG328253 pooled Gene CREB3L4, variant not shown         Submitted on the opposite strand    
AI620796 Prostate Gene CREB3L4, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BP271451 small intestine Gene CREB3L4, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC